Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Abbott Laboratories (Pakistan)'s
Operating Income
for the
three
months ended in Mar. 2026 was ₨3,121 Mil. Abbott Laboratories (Pakistan)'s Interest Expense for the
three
months ended in Mar. 2026 was ₨-18 Mil.
Abbott Laboratories (Pakistan)'s interest coverage for the quarter that ended in Mar. 2026 was 171.95.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Abbott Laboratories (Pakistan) Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Abbott Laboratories (Pakistan)'s Interest Coverage or its related term are showing as below:
KAR:ABOT'
s Interest Coverage Range Over the Past 10 Years
Min: 57 Med: 170.35 Max: 771.59
Current: 162.27
KAR:ABOT's Interest Coverage is ranked better than 83.92% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs KAR:ABOT: 162.27
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Abbott Laboratories (Pakistan) Interest Coverage Related Terms
Abbott Laboratories (Pakistan) Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
KAR:ABOT vs ZTS, UTHR, VTRS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories (Pakistan) Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s Interest Coverage distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories (Pakistan)'s Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (Pakistan) (KAR:ABOT) has a Interest Coverage of 171.95 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Abbott Laboratories (Pakistan) and its competitors. This is near median its historical median of 170.35. Over the past decade, Abbott Laboratories (Pakistan)'s Interest Coverage has ranged from 57.00 to 771.59. According to the industry distribution chart, Abbott Laboratories (Pakistan) ranks #110 out of 684 companies in the Drug Manufacturers industry, placing it in the top 16.1%.
Is Abbott Laboratories (Pakistan)'s Interest Coverage too high?
Abbott Laboratories (Pakistan)'s current Interest Coverage of 171.95 is near median its 10-year median of 170.35. Over the past 10 years, this metric has ranged from a low of 57.00 to a high of 771.59. The Drug Manufacturers industry median Interest Coverage is 12.77. Abbott Laboratories (Pakistan)'s value of 171.95 is 1247% above this industry median. Based on the distribution chart, Abbott Laboratories (Pakistan) ranks #110 out of 684 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Abbott Laboratories (Pakistan) has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories (Pakistan)'s Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Abbott Laboratories (Pakistan) ranks #110 out of 684 companies for Interest Coverage. This places Abbott Laboratories (Pakistan) in the top 16% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.77. Abbott Laboratories (Pakistan)'s value of 171.95 is 1247% above this benchmark. Historically, Abbott Laboratories (Pakistan)'s own Interest Coverage has ranged from 57.00 to 771.59 over the past decade. While the company's 10-year median is 170.35 vs. the industry median of 12.77, Abbott Laboratories (Pakistan) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories (Pakistan)'s current Interest Coverage of 171.95 is 1247% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Abbott Laboratories (Pakistan) and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories (Pakistan)'s current Interest Coverage is 171.95, which is near median its own 10-year median of 170.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories (Pakistan) stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) (KAR:ABOT) is currently considered Fairly Valued. The stock's GF Value™ is ₨1,001.38, compared to a current price of ₨970.76 — trading 3.1% below its estimated fair value. The current Interest Coverage is 171.95, which is near median its 10-year median of 170.35 and 1247% above the Drug Manufacturers industry median of 12.77. Abbott Laboratories (Pakistan)'s overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Abbott Laboratories (Pakistan) (KAR:ABOT), the current Interest Coverage is 171.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (Pakistan) (KAR:ABOT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) stock appears to be undervalued.
The current stock price of ₨970.76 is trading 3.1% below its estimated GF Value™ of ₨1,001.38.
GuruFocus considers Abbott Laboratories (Pakistan) to be Fairly Valued.
Key valuation signals for KAR:ABOT:
Interest Coverage: 171.95 (near median its 10-year median of 170.35)
GF Value™: ₨1,001.38 vs. price of ₨970.76 (3.1% below fair value)
Industry Position: 1247% above the Drug Manufacturers median (#110 of 684)
No single metric tells the full story. See the KAR:ABOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott Laboratories (Pakistan) Business Description
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. The company's Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
77GF Score
Get the complete analysis for KAR:ABOT
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:ABOT has been successfully added to your 
